Characterization of Shigella sonnei in Malaysia, an increasingly prevalent etiologic agent of local shigellosis cases
- PMID: 22606962
- PMCID: PMC3420240
- DOI: 10.1186/1471-2334-12-122
Characterization of Shigella sonnei in Malaysia, an increasingly prevalent etiologic agent of local shigellosis cases
Abstract
Background: Shigellosis is a major public health concern worldwide, especially in developing countries. It is an acute intestinal infection caused by bacteria of the genus Shigella, with a minimum infective dose as low as 10-100 bacterial cells. Increasing prevalence of Shigella sonnei as the etiologic agent of shigellosis in Malaysia has been reported. As there is limited information on the genetic background of S. sonnei in Malaysia, this study aimed to characterize Malaysian S. sonnei and to evaluate the prospect of using multilocus variable-number tandem-repeat (VNTR) analysis (MLVA) for subtyping of local S. sonnei.
Methods: Forty non-repeat clinical strains of S. sonnei isolated during the years 1997-2000, and 2007-2009 were studied. The strains were isolated from stools of patients in different hospitals from different regions in Malaysia. These epidemiologically unrelated strains were characterized using biotyping, antimicrobial susceptibility testing, pulsed-field gel electrophoresis (PFGE) and MLVA.
Results: The two biotypes identified in this study were biotype a (n = 29, 73%) and biotype g (n = 11, 27%). All the 40 strains were sensitive to kanamycin, ceftriaxone and ciprofloxacin. Highest resistance rate was observed for streptomycin (67.5%), followed by tetracycline (40%) and trimethoprim-sulfamethoxazole (37.5%). All the S. sonnei biotype g strains had a core resistance type of streptomycin - trimethoprim-sulfamethoxazole - tetracycline whereas the 29 biotype a strains were subtyped into eight resistotypes. All the strains were equally distinguishable by PFGE and MLVA. Overall, PFGE analysis indicated that S. sonnei biotype a strains were genetically more diverse than biotype g strains. Cluster analysis by MLVA was better in grouping the strains according to biotypes, was reflective of the epidemiological information and was equally discriminative as PFGE.
Conclusions: The S. sonnei strains circulating in Malaysia throughout the period studied were derived from different clones given their heterogeneous nature. MLVA based on seven selected VNTR loci was rapid, reproducible and highly discriminative and therefore may complement PFGE for routine subtyping of S. sonnei.
Figures



Similar articles
-
Molecular typing of Shigella sonnei isolates circulating in Nanjing, China, 2007-2011.J Infect Dev Ctries. 2014 Dec 15;8(12):1525-32. doi: 10.3855/jidc.4933. J Infect Dev Ctries. 2014. PMID: 25500650
-
Characterization of Shigella sonnei isolates from travel-associated cases in Japan.J Med Microbiol. 2009 Nov;58(Pt 11):1486-1491. doi: 10.1099/jmm.0.011809-0. Epub 2009 Jul 9. J Med Microbiol. 2009. PMID: 19589900
-
Shigella sonnei biotype G carrying class 2 integrons in southern Italy: a retrospective typing study by pulsed field gel electrophoresis.BMC Infect Dis. 2006 Jul 17;6:117. doi: 10.1186/1471-2334-6-117. BMC Infect Dis. 2006. PMID: 16846516 Free PMC article.
-
Prevalence of Shigella species and antimicrobial resistance patterns in Africa: systematic review and meta-analysis.BMC Infect Dis. 2024 Oct 29;24(1):1217. doi: 10.1186/s12879-024-09945-2. BMC Infect Dis. 2024. PMID: 39472797 Free PMC article.
-
Pathogenicity and virulence of Shigella sonnei: A highly drug-resistant pathogen of increasing prevalence.Virulence. 2023 Dec;14(1):2280838. doi: 10.1080/21505594.2023.2280838. Epub 2023 Nov 23. Virulence. 2023. PMID: 37994877 Free PMC article. Review.
Cited by
-
Clinical Trial of an Oral Live Shigella sonnei Vaccine Candidate, WRSS1, in Thai Adults.Clin Vaccine Immunol. 2016 Jul 5;23(7):564-75. doi: 10.1128/CVI.00665-15. Print 2016 Jul. Clin Vaccine Immunol. 2016. PMID: 27146000 Free PMC article. Clinical Trial.
-
Diversity of Variable Number Tandem Repeat Loci in Shigella Species Isolated from Pediatric Patients.Int J Mol Cell Med. 2015 Summer;4(3):174-81. Int J Mol Cell Med. 2015. PMID: 26629486 Free PMC article.
-
Shigella in Brazilian children with acute diarrhoea: prevalence, antimicrobial resistance and virulence genes.Mem Inst Oswaldo Cruz. 2013 Feb;108(1):30-5. doi: 10.1590/s0074-02762013000100005. Mem Inst Oswaldo Cruz. 2013. PMID: 23440111 Free PMC article.
-
A 10-year surveillance of antimicrobial susceptibility patterns in Shigella sonnei isolates circulating in Jiangsu Province, China.J Glob Antimicrob Resist. 2017 Sep;10:29-34. doi: 10.1016/j.jgar.2017.03.009. Epub 2017 Jun 9. J Glob Antimicrob Resist. 2017. PMID: 28606485 Free PMC article.
-
Adaptation of a fluoroquinolone-sensitive Shigella sonnei to norfloxacin exposure.R Soc Open Sci. 2024 Jun 19;11(6):232025. doi: 10.1098/rsos.232025. eCollection 2024 Jun. R Soc Open Sci. 2024. PMID: 39100177 Free PMC article.
References
-
- Levinson W. Medical Microbiology and Immunology: Examination and Board Review. Eighth edition. The McGraw-Hill Companies, New York; 2004. Basic bacteriology & brief summaries of medically important organisms; pp. 30–476.
-
- World Health Organization. Future needs and directions for Shigella vaccines. Wkly Epidemiol Rec. 2006;81:51–58. - PubMed
-
- World Health Organization. Initiative for Vaccine Research (IVR): Diarrhoeal Diseases (Updated February 2009). Shigellosis. http://www.who.int/vaccine_research/diseases/diarrhoeal/en/index6.html.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials